DCM
FENC icon

DG Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

DG Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-84,213
Closed -$513K – 26
2025
Q1 		$513K Sell
84,213
-1,030,479
-92% -$6.62M 0.18% 21
2024
Q4 		$7.04M Sell
1,114,692
-407,512
-27% -$2.09M 2.37% 14
2024
Q3 		$7.61M Sell
1,522,204
-112,607
-7% -$651K 3.45% 9
2024
Q2 		$9.99M Buy
1,634,811
+123,148
+8% +$1.02M 3.85% 8
2024
Q1 		$16.8M Buy
1,511,663
+436,029
+41% +$4.38M 10.3% 3
2023
Q4 		$12.1M Sell
1,075,634
-67,465
-6% -$559K 7.46% 8
2023
Q3 		$8.58M Buy
1,143,099
+68,445
+6% +$557K 4.7% 10
2023
Q2 		$9.49M Sell
1,074,654
-175,442
-14% -$1.46M 4.23% 10
2023
Q1 		$10.4M Buy
1,250,096
+228,144
+22% +$2.12M 5.85% 7
2022
Q4 		$9.81M Buy
1,021,952
+16,851
+2% +$149K 5.66% 8
2022
Q3 		$8.14M Sell
1,005,101
-205,537
-17% -$1.41M 3.58% 14
2022
Q2 		$6.84M Hold
1,210,638
– – 2.46% 17
2022
Q1 		$6.78M Buy
1,210,638
+51,249
+4% +$258K 1.36% 20
2021
Q4 		$5.1M Buy
1,159,389
+540,938
+87% +$4.03M 0.84% 22
2021
Q3 		$5.83M Buy
618,451
+29,678
+5% +$223K 1.18% 21
2021
Q2 		$4.29M Buy
+588,773
New +$3.93M 0.93% 26

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DG Capital Management's FENC Position: Q2 2025 in Review

DG Capital Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2025, closing a stake of 84,213 shares — an estimated $513K sold.

DG Capital Management first reported a position in FENC in Q2 2021 and held it in 16 quarters. The position peaked at $16.8M in Q1 2024. 78 funds tracked by Wall St. Rank hold FENC as of Q2 2025.

  • DG Capital Management reported no remaining Fennec Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • DG Capital Management sold 84,213 Fennec Pharmaceuticals shares in Q2 2025, an estimated $513K.
  • DG Capital Management first reported a position in Fennec Pharmaceuticals in Q2 2021 and held it in 16 quarters.
  • DG Capital Management's Fennec Pharmaceuticals position peaked at $16.8M in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2025.

Based on DG Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.